Abstract
Abstract: Medicines and medical resources are necessities of human society, and human beings often rely on them to speed up recovery or save lives. Especially since the society has just experienced an epidemic, namely COVID-19, the pharmaceutical industry is often in the spotlight. The prospects of the pharmaceutical industry are optimistic, and people often make profits by purchasing a company's stock. This study will analyze and evaluate the operating status of the four leader companies in the pharmaceutical market through data and theories, in order to figure out the most suitable company to buy shares. By comparing various data, Bristol-Myers Squibb's stock is the most suitable to buy. Because it has great potential in the future, high profitability, and high operation efficiency. The significance of this study is to enable people to discover companies worth investing in, provide professional advice to buyers, promote audiences for worthy companies, and discover companies with development prospects for the market.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Advances in Economics, Management and Political Sciences
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
